LEAP2 ameliorates high fat diet-impaired glucose tolerance and enhances glucose-stimulated insulin secretion from β cells through PPARγ signal pathway

Jiaxi Li,Mei Li,Hao Ke,Yang Han,Yanhong Huang,Yan Zhou,Ziqiang Luo,Chen Chen,Dandan Feng
DOI: https://doi.org/10.1097/cm9.0000000000003215
IF: 6.133
2024-09-21
Chinese Medical Journal
Abstract:To the Editor: Type 2 diabetes (T2D) is an endocrine system disease, characterized by persistent hyperglycemia, and is one of the most common and fastest growing diseases in the world. [ 1 ] Although significant progresses have been made in understanding the pathology of T2D with abnormal insulin-secretion profiles, the molecular and cellular mechanisms of β cells remain largely uncertain. Moreover, the liver-expressed antimicrobial peptide 2 (LEAP2) may antagonize the inhibition effect of ghrelin on insulin secretion by inhibiting the ghrelin receptor (growth hormone secretagogue receptor, GHSR). The regulation of glucose homeostasis by the ghrelin–LEAP2–GHSR axis remains largely unknown. It is hypothesized that the ghrelin–LEAP2–GHSR axis may regulate the insulin–glucose homeostasis in diabetic condition.
medicine, general & internal
What problem does this paper attempt to address?